Adverse events that occurred in the entire study period in the ‘whole-body vibration (WBV) only’ and ‘Control-WBV’ (initial control, subsequent WBV) groups (n=11 each), as well as in the entire cohort (n=22)
| WBV only (n=11) | Control-WBV (n=11) | All (n=22) | |
|---|---|---|---|
| Adverse events | |||
| Sore muscles (n, %) | 3 (27) | 5 (46) | 8 (36) |
| Back pain (n, %) | 1 (9) | 0 | 1 (9) |
| Dizziness (n, %) | 0 | 0 | 0 |
| Syncope (n, %) | 0 | 0 | 0 |